QSIAW
Quantum-Si incorporatedNASDAQ
Key Statistics
Market Cap
$1.44B
P/E Ratio
—
EPS
—
Beta
3.16
52W High
$1.08
52W Low
$0.06
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Quantum-Si incorporated
Quantum-Si Incorporated is a cutting-edge life sciences technology company specializing in the advancement of protein sequencing through its proprietary single-molecule technology and unique quantum dot capabilities. By providing high-throughput and cost-effective sequencing solutions, the company aims to revolutionize protein analysis, facilitating significant advancements in genomics and personalized medicine. Backed by a robust intellectual property portfolio, Quantum-Si is strategically positioned to capitalize on the growing demand for innovative sequencing technologies in both academic and clinical environments, driving forward life sciences research and applications.
Fundamentals
| Revenue (TTM) | $2.44M |
| Gross Profit (TTM) | $1.15M |
| EBITDA | $-92.59M |
| Operating Margin | -4677.00% |
| Return on Equity | -46.50% |
| Return on Assets | -24.60% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $1.02 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -62.20% |
| Shares Outstanding | 0 |
| Float | $177.94M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
171.28%
HV 20-Day
152.93%
HV 30-Day
183.19%
HV 60-Day
178.18%
HV Rank
—
Volatility is currently contracting
Data last updated: 5/5/2026